Envarsus XR
by Veloxis Pharmaceuticals
Envarsus XR (tacrolimus) is an immunosuppressant prescribed for adults who have undergone a kidney transplant to prevent rejection of the transplanted organ. The “XR” indicates that it is an extended-...
Envarsus XR (tacrolimus) is an immunosuppressant prescribed for adults who have undergone a kidney transplant to prevent rejection of the transplanted organ. The “XR” indicates that it is an extended-release medication. The intent is to maintain a steady level over 24 hours. It prevents the level of the active ingredient, tacrolimus, from becoming too high, which can be harmful. It is prescribed in conjunction with other anti-rejection drugs.
Envarsus XR is taken once daily, at the same time each day. It should be swallowed with water on an empty stomach at least 1 hour before or 2 hours after a meal, preferably in the morning.
Patient assistance programs
Envarsus XR Patient Assistance Program
Manufacturer PAP- Eligibility
- Patients who meet income and insurance requirements
- Income limit
- Varies — contact ClariMeds for current limits
- Insurance
- Typically uninsured or underinsured; Medicare/Medicaid restrictions may apply
- How to apply
- Apply through ClariMeds — we handle the paperwork at no cost
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free